Of the seven signature CpG sites, only cg10054641 is a promoter CpG and regulates TMEM71 expression, which has been proven to be associated with malignancy and TMZ resistance in glioma (Wang et al., 2019). This evidence concerns the gene TMEM71 and central nervous system cancer.